Tyrx produces antibacterial pouches, or envelopes, for medical devices to reduce risk of infection following device implantation. The company’s main product is the AIGISRx Antibacterial Envelope, which is placed around implants prior to implantation and eventually dissolve after releasing antimicrobial agents.
Tyrx’s pouches have been cleared to use with spinal cord stimulators and cardiac implants.
More Articles on Devices:
19 Spine Devices Receive FDA 510(k) Clearance in December
DePuy Synthes Spine Launches Bone Matrix Tissue Implant for Spinal Fusion
SI-BONE Celebrates 10k iFuse Implant System Uses Worldwide
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
